1. Opportunity Analysis and Industry Forecast, 2016-2023 Cancer Vaccines Market Global Opportunity Analysis and Industry Forecast, 2017-2023

2. The global cancer vaccines market was valued at $4,073 million in 2016, and is projected to reach at $12,814 million by 2023, growing at a CAGR of 17.7% from 2017 to 2023. The recombinant cancer vaccines segment accounted for one-third share of the global market in 2016. Vaccines include antigenic components, which strengthens an individuals immune system by developing adaptive immunity to prevent morbidity from infections. Cancer vaccine is a type of immunotherapy that boost the bodys natural defenses by stimulating the immune system to recognize and cure cancerous cells. The global market is driven by rise in prevalence of HPV infections and related cancer, increase in administration of prophylactic cancer vaccines, surge in investments & findings in the development of cancer vaccines, and launch of novel cancer vaccines in the market. However, longer timelines required for manufacturing a single vaccine restrain the development of new vaccines; thereby, hampering the market growth. In addition, high monetary inputs for the development of cancer vaccines decrease their adoption in the market; thereby, hampering the market growth. Introduction of Cancer Vaccines Market

3. Scope ofthe Report Key Benefits Key Audiences Introduction of Cancer Vaccines Market

4. Key Benefits The dendritic cells cancer vaccines segment is anticipated to grow at the highest rate during the forecast period. The preventive cancer vaccines segment dominated the global market, accounting for five- ninths share of the global market in 2016. North America dominated the global market, accounting for the maximum share of overall market in 2016, and is expected to continue this trend throughout the forecast period. Asia-Pacific is exhibited to grow at a CAGR of 19.6% during the forecast period, owing to the high demand for vaccination in densely populated countries, such as India and China. The cervical cancer segment generated the highest revenue in 2016, and is expected to continue its dominance in the near future. The pediatric vaccines segment is expected to exhibit high growth rate during forecast period, owing to the increase in demand for preventive cancer vaccines.

5. Table of Content (TOC) Chapter: 1 Introduction Chapter: 2 Executive Summary Chapter: 3 Market Overview Chapter: 4 Cancer Vaccines Market, By Technology Chapter: 5 Cancer Vaccines Market, By Type Chapter: 6 Cancer Vaccines, By Indication Chapter: 7 Cancer Vaccines Market, By End Use Chapter: 8 Company Profiles

6. Segments Cancer Vaccines Market

7. Segments Cancer Vaccines Market

8. Segments Cancer Vaccines Market

9. Company Profiles Cancer Vaccines Market 1.ASTRAZENECA PLC. (MEDIMMUNE, LLC.) 2.GLAXOSMITHKLINE PLC. 3.MERCK & CO., INC. 4.SANOFI PASTEUR 5.ADURO BIOTECH INC. 6.SANPOWER GROUP CO., LTD.

10. Follow Us On Thank You! For More Details Do Enquiry https://www.alliedmarketresearch.com/cancer-vaccines-market Thank You Cancer Vaccines Market